We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Automatic Analyzer Detects Sexually Transmitted Disease

By LabMedica International staff writers
Posted on 08 Jun 2010
An automated immunoassay system has been expanded to include a broad range of infectious diseases.

A continuous random access analyzer with processing throughput of 200 tests per hour has been designed specifically for optimum efficiency and consolidation in medium- and high-volume laboratories. More...
Laboratory clinicians will benefit, as access to high quality testing will streamline workflow leading to rapid diagnosis.

The advanced immunoassay system, called IMMULITE 2000, has 24 resident assays, which can be increased to as many as 96 diagnostic tests. The analyzer, manufactured by Siemens Healthcare Diagnostics (Erlangen, Germany), has added more infectious disease diagnostic capability to the system. Included in the new panel of tests is one for syphilis, a sexually transmitted disease caused by the spirochetal bacterium Treponema pallidum.

Symptoms of syphilis may be mistaken for other diseases and go undiagnosed for many years. The late or tertiary stage can be fatal. According to U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), there was a 13% rise in syphilis infection rates from 2007 to 2008. The disease can also be transmitted congenitally from mother to child.

The IMMULITE 2000 assay menu includes tests for congenitally transmitted diseases, such as Toxoplasmosis, Rubella, and cytomegalovirus disease. Diagnostic immunoassays are available for Hepatitis, Epstein-Barr virus, and Helicobacter pylori infections, as well as many metabolic and medical conditions.

David Hickey, executive vice president at Siemens Healthcare Diagnostics, said, "Consolidating routine and infectious disease immunoassay testing on to a laboratory automation solution addresses one of the laboratory's biggest challenges—to improve operational efficiency while continuing to enhance the quality of testing results and patient care."

Related Links:
Siemens Healthcare Diagnostics
US Centers for Disease Control and Prevention


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Fusun Can (at left) is developing a test for detecting both resistance and virulence in Klebsiella pneumoniae (Photo courtesy of Koç University)

Rapid Diagnostic Breakthrough Simultaneously Detects Resistance and Virulence in Klebsiella Pneumoniae

Antibiotic resistance is a steadily escalating threat to global healthcare, making common infections harder to treat and increasing the risk of severe complications. One of the most concerning pathogens... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.